{
    "Trade/Device Name(s)": [
        "BD ProbeTec\u2122 Neisseria gonorrhoeae (GC) Qx Amplified DNA Assay"
    ],
    "Submitter Information": "BD Diagnostic Systems",
    "510(k) Number": "K081825",
    "Predicate Device Reference 510(k) Number(s)": [
        "K984631",
        "K003395"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LSL"
    ],
    "Summary Letter Date": "December 5, 2008",
    "Summary Letter Received Date": "December 9, 2008",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3390"
    ],
    "Regulation Name(s)": [
        "Neisseria spp. direct serological test reagents"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Neisseria gonorrhoeae DNA"
    ],
    "Specimen Type(s)": [
        "Female endocervical swab",
        "Male urethral swab",
        "Vaginal swab",
        "Urine"
    ],
    "Specimen Container(s)": [
        "Extraction Tube"
    ],
    "Instrument(s)/Platform(s)": [
        "BD Viper\u2122 System"
    ],
    "Method(s)/Technology(ies)": [
        "Strand Displacement Amplification (SDA)",
        "Fluorescent probe detection"
    ],
    "Methodologies": [
        "Nucleic acid amplification",
        "Automated extraction",
        "Qualitative DNA detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for BD ProbeTec Neisseria gonorrhoeae Qx Amplified DNA Assay utilizing strand displacement amplification on the BD Viper System for qualitative detection of N. gonorrhoeae DNA.",
    "Indications for Use Summary": "Direct, qualitative detection of Neisseria gonorrhoeae DNA in clinician-collected female endocervical and male urethral swabs, patient-collected vaginal swabs, and male and female urine to aid diagnosis of gonococcal urogenital disease in asymptomatic and symptomatic females and symptomatic males.",
    "fda_folder": "Microbiology"
}